David Lawrence, Chief Financial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 9,313 shares at $24.21 ($225K) on 2012-12-03, disclosed to the SEC on 2012-12-05.
Scheduled sale ($225k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |